Immediate Impact
1 by Nobel laureates 3 from Science/Nature 63 standout
Citing Papers
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study
2020 Standout
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
2017 Standout
Works of Serena Rupoli being referenced
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.
2006
Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphoma.
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Serena Rupoli | 524 | 457 | 454 | 494 | 55 | 1.3k | |
| Ingrid Simonitsch | 359 | 486 | 292 | 239 | 54 | 1.4k | |
| Mireia Camós | 559 | 642 | 222 | 483 | 56 | 1.7k | |
| Monia Lunghi | 1066 | 346 | 186 | 621 | 60 | 1.7k | |
| Kaaren K. Reichard | 498 | 562 | 180 | 590 | 116 | 1.7k | |
| AA Morley | 386 | 741 | 142 | 460 | 23 | 1.5k | |
| K. F. Wong | 302 | 678 | 224 | 246 | 55 | 1.3k | |
| Michihide Tokuhira | 410 | 390 | 73 | 316 | 79 | 1.4k | |
| S Pileri | 159 | 441 | 233 | 206 | 35 | 1.3k | |
| Judit Demeter | 415 | 535 | 94 | 543 | 107 | 1.5k | |
| M. Uppenkamp | 356 | 553 | 108 | 378 | 64 | 1.6k |
All Works
Loading papers...